EXPO vs PFE · P/E 28, rev $337.9M vs P/E 20, rev $15.03B
Exponent Inc (EXPO) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Exponent Inc (EXPO) is a engineering & construction company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported EXPO revenue for 2026-07-03 was $337.9M. Net income was $59.0M. EXPO currently screens at market cap $2.89B and trailing P/E 27.9.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
EXPO currently screens at market cap $2.89B and trailing P/E 27.9. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the EXPO and PFE stock pages for the full models.
Not investment advice.